These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8099774)

  • 1. The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.
    Miller DB; O'Callaghan JP
    Ann N Y Acad Sci; 1993 May; 679():321-4. PubMed ID: 8099774
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.
    Miller DB; O'Callaghan JP
    Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
    Farfel GM; Vosmer GL; Seiden LS
    Brain Res; 1992 Nov; 595(1):121-7. PubMed ID: 1361410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.
    O'Callaghan JP; Miller DB
    J Pharmacol Exp Ther; 1994 Aug; 270(2):741-51. PubMed ID: 8071867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.
    Miller DB; O'Callaghan JP
    J Pharmacol Exp Ther; 1994 Aug; 270(2):752-60. PubMed ID: 8071868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
    Schmidt CJ; Black CK; Taylor VL
    Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
    Nash JF; Yamamoto BK
    Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole.
    Green AR; De Souza RJ; Williams JL; Murray TK; Cross AJ
    Neuropharmacology; 1992 Apr; 31(4):315-21. PubMed ID: 1381816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse.
    Johnson EA; O'Callaghan JP; Miller DB
    Brain Res; 2002 Apr; 933(2):130-8. PubMed ID: 11931857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevations in plasmatic titers of corticosterone and aldosterone, in the absence of changes in ACTH, testosterone, or glial fibrillary acidic protein, 72 h following D,L-fenfluramine or D-fenfluramine administration to rats.
    Williams MT; Morford LL; McCrea AE; Inman-Wood SL; Vorhees CV
    Neurotoxicol Teratol; 2001; 23(1):23-32. PubMed ID: 11274873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801.
    Dragunow M; Logan B; Laverty R
    Eur J Pharmacol; 1991 Mar; 206(3):255-8. PubMed ID: 1677338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low environmental temperatures or pharmacologic agents that produce hyperthermia decrease methamphetamine neurotoxicity in mice.
    Ali SF; Newport RR; Holson W; Slikker W; Bowyer JF
    Ann N Y Acad Sci; 1995 Sep; 765():338. PubMed ID: 7486639
    [No Abstract]   [Full Text] [Related]  

  • 14. Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine.
    Schmidt CJ; Black CK; Abbate GM; Taylor VL
    Eur J Pharmacol; 1990 Nov; 191(2):213-6. PubMed ID: 1982264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats.
    Finnegan KT; Calder L; Clikeman J; Wei S; Karler R
    Brain Res; 1993 Feb; 603(1):134-8. PubMed ID: 8095837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity.
    Gibb JW; Johnson M; Hanson GR
    NIDA Res Monogr; 1989; 95():511. PubMed ID: 2577049
    [No Abstract]   [Full Text] [Related]  

  • 17. Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
    Lehmann J; DeSouza EB; Culp S; Zaczek R
    Ann N Y Acad Sci; 1992 May; 648():291-5. PubMed ID: 1379013
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
    Schmidt CJ; Black CK; Abbate GM; Taylor VL
    Brain Res; 1990 Oct; 529(1-2):85-90. PubMed ID: 1980848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
    Taraska T; Finnegan KT
    J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.